Northen; Julian Scott

Patent Applications and Registrations

Patent applications and USPTO patent grants for Northen; Julian Scott.The latest application filed is for "methods of treating neurocognitive disorders, chronic pain and reducing inflammation".

Company Profile

14.14.17

Northen; Julian Scott - South Shields GB
Northen; Julian Scott - Sunderland GB
Northen; Julian Scott - Tyne and Wear GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use Grant 11,447,510 - Londesbrough , et al. September 20, 2	2022-09-20
Methods Of Treating Neurocognitive Disorders, Chronic Pain And Reducing Inflammation App 20220169668 - LONDESBROUGH; Derek John ; et al.	2022-06-02
Crystalline forms of plasma kallikrein inhibitors Grant 11,306,061 - Sinha , et al. April 19, 2	2022-04-19
Method For Treating Anxiety Disorders, Headache Disorders, And Eating Disorders With Psilocybin App 20220088041 - LONDESBROUGH; Derek John ; et al.	2022-03-24
Preparation Of Psilocybin, Different Polymorphic Forms, Intermediates, Formulations And Their Use App 20220073548 - LONDESBROUGH; Derek John ; et al.	2022-03-10
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use Grant 11,180,517 - Londesbrough , et al. November 23, 2	2021-11-23
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use Grant 11,149,044 - Londesbrough , et al. October 19, 2	2021-10-19
Preparation Of Psilocybin, Different Polymorphic Forms, Intermediates, Formulations And Their Use App 20210246152 - LONDESBROUGH; Derek John ; et al.	2021-08-12
Preparation Of Psilocybin, Different Polymorphic Forms, Intermediates, Formulations And Their Use App 20210155642 - LONDESBROUGH; Derek John ; et al.	2021-05-27
Solid Forms Of Cerdulatinib App 20210130330 - Pandey; Anjali ; et al.	2021-05-06
Preparation Of Psilocybin, Different Polymorphic Forms, Intermediates, Formulations And Their Use App 20210087212 - LONDESBROUGH; Derek John ; et al.	2021-03-25
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use Grant 10,954,259 - Londesbrough , et al. March 23, 2	2021-03-23
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use Grant 10,947,257 - Londesbrough , et al. March 16, 2	2021-03-16
Process for preparing purine derivatives Grant 10,927,113 - Skead , et al. February 23, 2	2021-02-23
Solid forms of cerdulatinib Grant 10,865,198 - Pandey , et al. December 15, 2	2020-12-15
Preparation Of Psilocybin, Different Polymorphic Forms, Intermediates, Formulations And Their Use App 20200331939 - LONDESBROUGH; Derek John ; et al.	2020-10-22
Preparation Of Psilocybin, Different Polymorphic Forms, Intermediates, Formulations And Their Use App 20200199161 - LONDESBROUGH; Derek John ; et al.	2020-06-25
Solid Forms Of Cerdulatinib App 20200031804 - Pandey; Anjali ; et al.	2020-01-30
Salt Of A Pyrimido[6,1-a]isoquinolin-4-one Compound App 20200016158 - Spargo; Peter Lionel ; et al.	2020-01-16
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use Grant 10,519,175 - Londesbrough , et al. Dec	2019-12-31
Salt of a pyrimido[6,1-A]isoquinolin-4-one compound Grant 10,463,665 - Spargo , et al. No	2019-11-05
Preparation Of Psilocybin, Different Polymorphic Forms, Intermediates, Formulations And Their Use App 20190119310 - Londesbrough; Derek John ; et al.	2019-04-25
Salt Of A Pyrimido[6,1-a]isoquinolin-4-one Compound App 20180021337 - Spargo; Peter Lionel ; et al.	2018-01-25
Crystalline forms of a purine derivative Grant 9,573,951 - Skead , et al. February 21, 2	2017-02-21
Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-- 2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride Grant 9,512,065 - Northen , et al. December 6, 2	2016-12-06
Polymorphs Of N-[(r)-1-[(s)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-- 2-(4-ethoxy-phenyl)-ethyl]-benzamide Hydrochloride App 20150191421 - Northen; Julian Scott ; et al.	2015-07-09
Crystalline Forms Of A Purine Derivative App 20150148354 - SKEAD; Benjamin Mark ; et al.	2015-05-28
Crystalline forms of a purine derivative Grant 8,889,861 - Skead , et al. November 18, 2	2014-11-18
Crystalline Forms Of A Purine Derivative App 20130072504 - Skead; Benjamin Mark ; et al.	2013-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.